Stay updated on mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Sign up to get notified when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version as v2.15.2, replacing the previous version v2.15.0. Additionally, the phrasing regarding the last update has been clarified.
    Difference
    0.1%
    Check dated 2025-04-30T14:26:05.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page has updated contact information for several oncology professionals, replacing some names and phone numbers while adding new contacts. Additionally, the last update date has been changed to reflect a more recent timeline.
    Difference
    3%
    Check dated 2025-04-23T14:02:42.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study descriptions and key inclusion/exclusion criteria for a clinical trial related to melanoma, while adding new terms such as 'Melanoma' and 'mRNA-4157-P201'.
    Difference
    16%
    Check dated 2025-04-16T11:14:50.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 13, 2025. However, there are no significant changes in core content, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-04-09T05:25:02.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:38:44.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new contact number and email for the Moderna WeCare Team, as well as an increase in the number of study locations from 21 to 22, including specific details about a location in Atlanta, Georgia.
    Difference
    2%
    Check dated 2025-03-18T07:16:52.000Z thumbnail image

Stay in the know with updates to mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.